about
Considerations for using genetic and epigenetic information in occupational health risk assessment and standard settingToxicogenomic profiling of chemically exposed humans in risk assessmentGenomics era and complex disorders: Implications of GWAS with special reference to coronary artery disease, type 2 diabetes mellitus, and cancersExposome informatics: considerations for the design of future biomedical research information systemsComparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking waterApplication of biclustering of gene expression data and gene set enrichment analysis methods to identify potentially disease causing nanomaterialsApplication of computational systems biology to explore environmental toxicity hazardsPerspectives on validation of high-throughput assays supporting 21st century toxicity testingAnalysis of the transcriptome in molecular epidemiology studiesThe Use of Signal-Transduction and Metabolic Pathways to Predict Human Disease Targets from Electric and Magnetic Fields Using in vitro Data in Human Cell LinesTargeted journal curation as a method to improve data currency at the Comparative Toxicogenomics Database.Protocol of the baseline assessment for the Environments for Healthy Living (EHL) Wales cohort study.Predicting environmental chemical factors associated with disease-related gene expression dataPreferential regulation of miRNA targets by environmental chemicals in the human genomeAquatic models, genomics and chemical risk management.The implications of relationships between human diseases and metabolic subpathways.MEDIC: a practical disease vocabulary used at the Comparative Toxicogenomics Database.The Comparative Toxicogenomics Database: update 2011.A genome-wide association scan on estrogen receptor-negative breast cancerIn vitro Toxicity Testing in the Twenty-First CenturyThe curation paradigm and application tool used for manual curation of the scientific literature at the Comparative Toxicogenomics Database.DiseaseComps: a metric that discovers similar diseases based upon common toxicogenomic profiles at CTD.Using bioinformatic approaches to identify pathways targeted by human leukemogensLessons from Toxicology: Developing a 21st-Century Paradigm for Medical ResearchImproving the human hazard characterization of chemicals: a Tox21 updatePublic databases supporting computational toxicology.High-Performance Prediction of Human Estrogen Receptor Agonists Based on Chemical Structures.Anthropometric assessment of a Middle Eastern group of autistic children.Modeling autism: a systems biology approach.The REACH perspective: toward a new concept of toxicity testing.A combined analysis of genome-wide association studies in breast cancer.A systems biology approach to predictive developmental neurotoxicity of a larvicide used in the prevention of Zika virus transmission.Rigorous Selection of Random Forest Models for Identifying Compounds that Activate Toxicity-Related Pathways
P2860
Q23919015-433A5035-B166-4FBB-BF86-6ADDE0BAD636Q24289420-7F2DB29D-5A0F-42A8-A045-C7685610A5ECQ26740000-CA628A37-DF46-43D1-9696-C0C6A434260AQ28384414-B2DFAE4F-CAF6-449F-A620-D8AD91189B6CQ28384756-E2454142-1E05-4B1E-9510-1BE7983BDE0EQ28385494-9A306970-BA8E-49BC-B45F-7623562D5BBCQ28395781-0BE0A773-E324-4366-90FC-3FCF58942F57Q28658651-2478FFB8-80AA-4E19-A0C0-5F99EE9A5A0BQ28817795-D1991286-54DE-43EF-85E6-A48B033FAF89Q28831207-ECFB3178-6ACE-4583-AA78-1B49F5A4D1ABQ30580650-7578A17C-1A53-4D79-8930-48B591183752Q33544889-BD73ACA9-5C77-4114-9B05-1D9ABB6906C9Q33575070-42112B93-0B7E-48BA-A849-65055043168EQ33904808-7785DC68-7B7B-4CBD-BEBA-F313FE5C38A7Q33924717-BC0237B2-DCFB-478E-89E6-330D46803431Q33939198-2E8B6D69-CD85-4DD3-B168-3E5DC590B703Q34204372-F99030D1-28DB-4021-B1D7-D7DC727AC37CQ34456573-8A5A3B23-5874-49E2-88DE-878887EB7FB1Q34613513-49B3ED9A-4695-472B-B606-F14BAB853E8DQ35037975-10B54DE7-2863-4EBA-B4AF-7EAA30FF1E73Q35223112-D6E3941B-36E9-4CB2-A817-CA3D73AEA229Q35562008-93EFCD89-ADA8-4865-BFC7-0F30AB0099D7Q36126146-5D2C1AC7-2477-4A83-8F9E-FF247118A327Q36239384-EAFC216C-1224-4EEF-98A4-931F89A30524Q36984065-AA0A0A47-A981-47C1-A0E2-F33B0BF9366EQ37767387-03B61BCC-6743-4EFA-B925-0677F68DB473Q38820537-2C13DE87-A057-4DB7-A705-1F3FAD7CF147Q39240800-CF8D6695-9031-4A57-9B76-A0A80C13FDBEQ42062971-C2797C99-D637-4075-A29F-238036EC3B58Q42665240-F26D72BB-D012-45E6-9F59-9C92D42F52D1Q42676622-12C77635-7059-4889-8201-530545857262Q50422053-5E4B683C-2D16-4A5B-A85A-BDE369D4B6ABQ57898160-C90EAB0A-6508-45B1-941C-7229563F5292
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Genetic and environmental pathways to complex diseases.
@ast
Genetic and environmental pathways to complex diseases.
@en
type
label
Genetic and environmental pathways to complex diseases.
@ast
Genetic and environmental pathways to complex diseases.
@en
prefLabel
Genetic and environmental pathways to complex diseases.
@ast
Genetic and environmental pathways to complex diseases.
@en
P2093
P2860
P50
P356
P1433
P1476
Genetic and environmental pathways to complex diseases.
@en
P2093
Allan P Davis
Carolyn J Mattingly
Cynthia Murphy
Michael C Rosenstein
Reuben Thomas
Yonqing Zhang
P2860
P2888
P356
10.1186/1752-0509-3-46
P577
2009-05-05T00:00:00Z
P5875
P6179
1022040724